Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New tool to uncover why turkish doctors Don't refer heart patients to rehab

NCT ID NCT06356428

Knowledge-focused Sponsor: Karamanoğlu Mehmetbey University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study translated and tested a questionnaire (PACRR-R) in Turkish to measure doctors' attitudes about referring heart patients to cardiac rehabilitation. 89 actively practicing physicians completed the survey. The goal is to provide a reliable tool to identify barriers and improve referral rates in Turkey.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

89 people

The number who actually took part.

Started

May 2024

Finished

Jan 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

The population of the study is physicians. The sample was physicians who volunteered to participate in the study, to whom the study could be announced/notified, and who provided active service in patient diagnosis and treatment. In the literature, it is stated that the number of individuals to be included in the study in order to achieve meaningful and valid results in the scale development process is at least 5 times the number of items in the scale and ideally 10 times. In our study, the number of individuals to be included in the study to test the validity of the scale was planned to be at least 100 individuals (PACRR-R consists of 20 items). In order to examine the test-retest reliability of the scale, it was planned to reapply the scale to at least 25% of the individuals in the sample.

Ages

25 to 70 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * To be a physician, * Providing active service in patient diagnosis and treatment Exclusion Criteria: * Not providing active service in patient diagnosis and treatment despite being a physician (administrative position, etc.).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Physician's role are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Physician's role

Contacts and locations

Locations

  • Karamanoglu Mehmetbey University

    Karaman, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.